Search research articles
Contact Us
Filters
Showing results (41-50 of 325) with videos related to
Page
of 33
Sort By:
Diabetes Spectrum : a Publication of the American Diabetes Association
|
February 4, 2015
Real-world evaluation of the effects of counseling and education in diabetes management
Mehul R Dalal, Scott B Robinson, Sean D Sullivan
Health Affairs (Project Hope)
|
January 7, 2015
Cost-effectiveness: the authors reply
Mark V Pauly, Frank A Sloan, Sean D Sullivan
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 6, 2008
Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma
Jonathan D Campbell, David K Blough, Sean D Sullivan
Diabetes, Obesity & Metabolism
|
April 21, 2021
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme
Lawrence Blonde, Timothy Bailey, Sean D Sullivan, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 24, 2025
Health care resource utilization and costs of commercially insured US patients with atopic dermatitis switching from first-line to second-line systemic targeted therapies
Kevin H Li, Shelly L Gray, Sean D Sullivan
The Diabetes Educator
|
May 4, 2013
The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetes
Sean D Sullivan, Mehul R Dalal, James P Burke
Medical Care
|
April 29, 2008
A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach
Scott D Ramsey, David K Blough, Sean D Sullivan
Journal of Managed Care & Specialty Pharmacy
|
February 28, 2025
Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States
Sean D Sullivan, Shruti Chaturvedi, Preety Gautam, et al.
Journal of Medical Economics
|
January 21, 2026
Calculating cost per event avoided using a composite number needed to treat
Joshua Toliver, Julia Wang, Jigish Bhavsar, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 23, 2024
Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States
Sean D Sullivan, Shruti Chaturvedi, Preety Gautam, et al.
Page
of 33
Search research articles
Search
Showing results (41-50 of 325) with videos related to
Sort By:
Page
of 33
Diabetes Spectrum : a Publication of the American Diabetes Association
|
February 4, 2015
Real-world evaluation of the effects of counseling and education in diabetes management
Mehul R Dalal, Scott B Robinson, Sean D Sullivan
Health Affairs (Project Hope)
|
January 7, 2015
Cost-effectiveness: the authors reply
Mark V Pauly, Frank A Sloan, Sean D Sullivan
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
December 6, 2008
Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma
Jonathan D Campbell, David K Blough, Sean D Sullivan
Diabetes, Obesity & Metabolism
|
April 21, 2021
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme
Lawrence Blonde, Timothy Bailey, Sean D Sullivan, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 24, 2025
Health care resource utilization and costs of commercially insured US patients with atopic dermatitis switching from first-line to second-line systemic targeted therapies
Kevin H Li, Shelly L Gray, Sean D Sullivan
The Diabetes Educator
|
May 4, 2013
The impact of diabetes counseling and education: clinical and cost outcomes from a large population of US managed care patients with type 2 diabetes
Sean D Sullivan, Mehul R Dalal, James P Burke
Medical Care
|
April 29, 2008
A forensic evaluation of the National Emphysema Treatment Trial using the expected value of information approach
Scott D Ramsey, David K Blough, Sean D Sullivan
Journal of Managed Care & Specialty Pharmacy
|
February 28, 2025
Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States
Sean D Sullivan, Shruti Chaturvedi, Preety Gautam, et al.
Journal of Medical Economics
|
January 21, 2026
Calculating cost per event avoided using a composite number needed to treat
Joshua Toliver, Julia Wang, Jigish Bhavsar, et al.
Journal of Managed Care & Specialty Pharmacy
|
December 23, 2024
Cost-effectiveness of caplacizumab in immune thrombotic thrombocytopenic purpura in the United States
Sean D Sullivan, Shruti Chaturvedi, Preety Gautam, et al.
Page
of 33